159 related articles for article (PubMed ID: 32000458)
1. Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review.
Li X; Wu Y; Suo P; Liu G; Li L; Zhang X; Chen S; Xu M; Song L
Medicine (Baltimore); 2020 Jan; 99(5):e19076. PubMed ID: 32000458
[TBL] [Abstract][Full Text] [Related]
2. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
4. Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy.
Yang J; Huang Y; Feng Y; Li H; Feng T; Chen J; Yin L; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
Cancer Res Treat; 2019 Jul; 51(3):1198-1206. PubMed ID: 30590005
[TBL] [Abstract][Full Text] [Related]
5. Thyroid Cancer, Neuroendocrine Tumor, Adrenal Adenoma, and Other Tumors in a Patient With a Germline
Alghamdi B; Al-Hindi H; Murugan AK; Alzahrani AS
J Endocr Soc; 2023 Mar; 7(5):bvad035. PubMed ID: 37143695
[TBL] [Abstract][Full Text] [Related]
6. Dominant mutations in S. cerevisiae PMS1 identify the Mlh1-Pms1 endonuclease active site and an exonuclease 1-independent mismatch repair pathway.
Smith CE; Mendillo ML; Bowen N; Hombauer H; Campbell CS; Desai A; Putnam CD; Kolodner RD
PLoS Genet; 2013 Oct; 9(10):e1003869. PubMed ID: 24204293
[TBL] [Abstract][Full Text] [Related]
7. Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant.
Landry KK; Seward DJ; Dragon JA; Slavik M; Xu K; McKinnon WC; Colello L; Sweasy J; Wallace SS; Cuke M; Wood ME
Cancer Genet; 2022 Jan; 260-261():30-36. PubMed ID: 34852986
[TBL] [Abstract][Full Text] [Related]
8. Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.
Vilarinho S; Erson-Omay EZ; Harmanci AS; Morotti R; Carrion-Grant G; Baranoski J; Knisely AS; Ekong U; Emre S; Yasuno K; Bilguvar K; Günel M
J Hepatol; 2014 Nov; 61(5):1178-83. PubMed ID: 25016225
[TBL] [Abstract][Full Text] [Related]
9. Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.
Wu IC; Liu WC; Chang TT
J Biomed Sci; 2018 Jun; 25(1):51. PubMed ID: 29859540
[TBL] [Abstract][Full Text] [Related]
10. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
[TBL] [Abstract][Full Text] [Related]
11. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: surveillance CT schedule after hepatectomy based on risk stratification.
Liu D; Fong DY; Chan AC; Poon RT; Khong PL
Radiology; 2015 Jan; 274(1):133-40. PubMed ID: 25162308
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus.
Liu WC; Wu IC; Lee YC; Lin CP; Cheng JH; Lin YJ; Yen CJ; Cheng PN; Li PF; Cheng YT; Cheng PW; Sun KT; Yan SL; Lin JJ; Yang JC; Chang KC; Ho CH; Tseng VS; Chang BC; Wu JC; Chang TT
J Pathol; 2017 Oct; 243(2):176-192. PubMed ID: 28696069
[TBL] [Abstract][Full Text] [Related]
14. Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.
Yan X; Shao C; Chen C; Chen J; Gu S; Huang L; Fu X; Zhao H; Qiu Y
Dig Dis Sci; 2017 Feb; 62(2):407-417. PubMed ID: 28058595
[TBL] [Abstract][Full Text] [Related]
15. [The significance of hepatic lobectomy as the surgical treatment for primary hepatocellular carcinoma].
Okamoto E; Toyosaka A; Yamanaka N; Tanaka N
Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):908-12. PubMed ID: 6328248
[TBL] [Abstract][Full Text] [Related]
16. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
17. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
[TBL] [Abstract][Full Text] [Related]
18. Enhanced patterns on intraoperative contrast-enhanced ultrasonography predict outcomes after curative liver resection in patients with hepatocellular carcinoma.
Nakamura I; Hatano E; Tada M; Kawabata Y; Tamagawa S; Kurimoto A; Iwama H; Toriguchi K; Sueoka H; Iida K; Yoshida M; Nishimura T; Iijima H
Surg Today; 2021 May; 51(5):764-776. PubMed ID: 32964250
[TBL] [Abstract][Full Text] [Related]
19. Hereditary nonpolyposis coloretal cancer: identification of novel germline mutations in two kindreds not fulfulling the Amsterdam criteria. Mutations in brief no. 203. Online.
Quaresima B; Grandinetti C; Baudi F; Tassone P; Barbieri V; Conforti S; Avvedimento EV; Costanzo F; Venuta S
Hum Mutat; 1998; 12(6):433. PubMed ID: 10671064
[TBL] [Abstract][Full Text] [Related]
20. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
